N-acetylcysteine exposure is associated with improved survival in anti-nuclear antibody seropositive patients with usual interstitial pneumonia
BMC Pulmonary Medicine Feb 14, 2018
Oldham JM, et al. - In this single center, retrospective cohort analysis, a hypothesis was tested that anti-nuclear antibodies (ANA) positive patients with usual interstitial pneumonia (UIP) would have improved outcome when exposed to the antioxidant N-acetylcysteine (NAC) compared to ANA negative patients. NAC exposure was found to be associated with improved transplant-free survival among ANA positive patients with UIP.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries